过表达miR-140-5p的人尿源性干细胞外泌体通过下调VEGFA减轻大鼠膝关节骨关节炎
该研究在大鼠膝关节骨关节炎(KOA)模型及体外白细胞介素1β诱导的骨关节炎模型中,评估过表达miR-140-5p的人尿源性干细胞外泌体(hUSC-140-Exos)的作用。结果显示hUSC-140-Exos在保留hUSC-Exos促进软骨细胞增殖和迁移、抑制凋亡优势的同时,通过靶向VEGFA增加细胞外基质分泌,并在大鼠模型中促进软骨再生和软骨下骨重建。
要点
- hUSC-Exos促进IL-1β处理的软骨细胞增殖和迁移并抑制凋亡,但减少细胞外基质分泌。
- hUSC-140-Exos通过靶向VEGFA增加胶原II和聚集蛋白聚糖的分泌。
- 大鼠KOA模型中关节腔内注射hUSC-140-Exos增强软骨再生和软骨下骨重建。
核心结论
- 过表达miR-140-5p的hUSC-Exos治疗骨关节炎优于hUSC-Exos。
- hUSC-140-Exos抑制KOA进展的作用部分由VEGFA介导。
研究设计与样本
- 对照实验室研究,包含体外IL-1β诱导的骨关节炎模型和大鼠KOA模型。
- 体外比较hUSC-Exos与hUSC-140-Exos对IL-1β处理的软骨细胞增殖、迁移、凋亡及细胞外基质分泌的作用。
- 通过小干扰RNA转染或化学药物研究VEGFA介导miR-140对OA有益作用的机制。
- 检测KOA患者软骨和滑液中VEGFA表达并与健康对照比较。
- 对Sprague-Dawley大鼠行前交叉韧带切断和内侧半月板失稳术建立OA模型,术后4至8周关节腔内注射hUSC-Exos或hUSC-140-Exos。
主要发现
- hUSC-Exos增强IL-1β处理的软骨细胞增殖和迁移能力并抑制凋亡,但伴随细胞外基质分泌减少。
- hUSC-140-Exos保留hUSC-Exos的优势,并通过靶向VEGFA增加细胞外基质分泌,包括胶原II和聚集蛋白聚糖。
- KOA患者软骨和滑液样本中VEGFA表达增加。
- 大鼠OA模型中关节腔内注射hUSC-140-Exos增强软骨再生和软骨下骨重建。
临床怎么用
- 作者认为干细胞来源外泌体可能为KOA提供有前景的治疗,本研究可推进相关基础研究。
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Knee osteoarthritis (KOA) is one of the most common chronic musculoskeletal disorders worldwide, for which exosomes derived from stem cells may provide an effective treatment. PURPOSE: To assess the effect of exosomes derived from human urine-derived stem cells (hUSCs) overexpressing miR-140-5p (miR means microRNA) on KOA in an in vitro interleukin 1β (IL-1β)-induced osteoarthritis (OA) model and an in vivo rat KOA model. STUDY DESIGN: Controlled laboratory study. METHODS: Exosomes derived from hUSCs (hUSC-Exos) were isolated and validated. The hUSCs were transfected with miR-140s using lentivirus, and exosomes secreted from such cells (hUSC-140-Exos) were collected. The roles of hUSC-Exos and hUSC-140-Exos in protecting chondrocytes against IL-1β treatment were compared by analyzing the proliferation, migration, apoptosis, and secretion of extracellular matrix (ECM) in chondrocytes. After vascular endothelial growth factor A (VEGFA) was identified as a target of miR-140, the mechanism by which VEGFA can mediate the beneficial effect of miR-140 on OA was investigated using small interfering RNA transfection or chemical drugs. The expression of VEGFA in cartilage and synovial fluid from patients with KOA was measured and compared with that of healthy controls. Surgery for anterior cruciate ligament transection and destabilization of the medial meniscus were performed on the knee joints of Sprague-Dawley rats to establish an animal model of OA, and intra-articular (IA) injection of hUSC-Exos or hUSC-140-Exos was conducted at 4 to 8 weeks after the surgery. Cartilage regeneration and subchondral bone remodeling were evaluated through histological staining and micro-computed tomography analysis. RESULTS: Proliferation and migration ability were enhanced and apoptosis was inhibited in chondrocytes treated with IL-1β via hUSC-Exos, with the side effect of decreased ECM secretion. hUSC-140-Exos not only retained the advantages of hUSC-Exos but also increased the secretion of ECM by targeting VEGFA, including collagen II and aggrecan. Increased expression of VEGFA during the progression of KOA was also confirmed in cartilage and synovial fluid samples obtained from patients with OA. In the rat OA model, IA injection of hUSC-140-Exos enhanced cartilage regeneration and subchondral bone remodeling. CONCLUSION: Our results demonstrated the superiority of hUSC-Exos overexpressing miR-140-5p for treating OA compared with the hUSC-Exos. The effect of hUSC-140-Exos for suppressing the progression of KOA is in part mediated by VEGFA. CLINICAL RELEVANCE: Exosomes derived from stem cells may provide a promising treatment for KOA, and our study can advance the related basic research.
引用
- Liu Y, Zeng Y, Si HB, et al. Exosomes Derived From Human Urine-Derived Stem Cells Overexpressing miR-140-5p Alleviate Knee Osteoarthritis Through Downregulation of VEGFA in a Rat Model. Am J Sports Med. 2022. PMID: 35179989. doi:10.1177/03635465221073991
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。